Recombinant t-PA acts beneficially on the ischemic microvasculature located downstream of the clot even before recanalization and despite occlusion by reducing microvascular thrombosis.3 We consider the following to be the main limitations of our work. The gene discussed is PLAT; the disease is Venous thrombosis.